Ann Lin

Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials

Ann Lin, Christopher J. Giuliano, Ann Palladino et al. · Science Translational Medicine · 2019 · 776 citations · Full text

Medicine, Cancer Biology, Oncology +6

Granulocyte-Macrophage Colony-Stimulating Factor Gene-Modified Autologous Tumor Vaccines in Non-Small-Cell Lung Cancer

John Nemunaitis, D. Sterman, David M. Jablons et al. · JNCI Journal of the National Cancer Institute · 2004 · 247 citations · Full text

Medicine, Immunology, Oncology +17

Wafer-Scale Growth and Transfer of Aligned Single-Walled Carbon Nanotubes

Nishant Patil, Ann Lin, Edward R. Myers et al. · IEEE Transactions on Nanotechnology · 2009 · 195 citations

Natural Sciences, Materials Engineering, Materials Science +13

Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX® vaccine in advanced-stage non-small-cell lung cancer

John Nemunaitis, Thierry Jahan, Helen J. Ross et al. · Cancer Gene Therapy · 2006 · 178 citations

Medicine, Immunology, Oncology +17

CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials

Ann Lin, Christopher J. Giuliano, Nicole M. Sayles et al. · eLife · 2017 · 142 citations · Full text

Life Sciences, Genetics, Oncology +15